August 20, 2018 5:20pm
I answer one question, in which company should investors put, keep and commit their money!
Re-framing the main takeaway … pricing, volume and volatility as “our” universe suffers from “tourist” investing.
Henry’omics:
Even on a supposed vacation, I present the short-version.
“The bull market turns 3,453 days old this Wednesday. Barring a 20% decline between now and then, it would mark the longest bull market in history, according to S&P. Since the current bull market started on March 9, 2009, the S&P 500 has surged more than 300%.” <CNBC>
The length of this bull market is unprecedented but so will be the declines …
Of the 45 companies covered on Monday; 16 downside equities finished in a range of -0.47% (NTLA) to -11.49% (KOOL) while the 23 upside equities oscillated from +0.20% (GBT) to +6.25% (AST) with 6 flat closes (RGNX, BSTG, VSTM, RENE.L, ATHX and ONVO).
From the pre-open newsletter: “there’s always something disturbing the sector. Beyond the jeopardies of clinical trials lately it’s algorithms, complacency and downright obliviousness to risk. When you point one finger, there are three fingers pointing back at you?”
I also stated, “Any uptrend in sector equities could be showing signs of “exhaustion”; historically speaking, this week tends to be quiet in terms of trading volume, as there is limited news after corporate earnings and the lack of economic data.”
Daily analytics and metrics:
- The Dow closed up +89.37 points of +0.35% to close at 25,758.69
- The S&P closed up +6.92 points or +0.24% to close at 2,857.05
- The NASDAQ closed up +4.68 points or +0.06% to close at 7,821.01
The advance/decline line scenario of 45 covered companies:
- The open was positive with an A/DL of 27/16 and 2 flats;
- The second hour was negative with an A/DL of 16/26 and 3 flats;
- The mid-day was barely positive with an A/DL of 22/21 and 2 flats;
- The close was positive with an A/DL of 23/16 and 6 flats;
MY working trend (5 largest) lines:
… The greatest volume to the downside: MDXG, BMRN, KOOL, BTX and ONCE
… Upside volume was weighted to: SGMO, ALNY, IONS, XON and EDIT
… Leadership ($) to the downside: SAGE (-$3.85), BMRN (-$1.98), ONCE (-$1.84), SLDB (-$1.36) and RARE (-$0.74)
… Best moves ($) to the upside: ALNY (+1.79), BLFS (+$1.06), QURE (+$1.05), CLLS (+$0.84) and IONS (+$0.83)
The iShares NASDAQ Biotechnology (IBB) closed:
- Monday was down -0.17%
- Friday was up +0.02%
- Thursday was up +0.77%
- Wednesday was down -1.56%
- Tuesday was up +0.56%
- Last Monday was down -0.15%
August sessions:
Monday closed POSITIVE with 16 decliners, 23 advancers and 6 flat;
Friday closed POSITIVE with 18 decliners, 24 advancers and 3 flat;
Thursday closed POSITIVE with 16 decliners, 27 advancers and 2 flat;
Wednesday closed NEGATIVE with 36 decliners, 6 advancers and 3 flat;
Tuesday closed POSITIVE with 13 decliners, 28 advancers and 4 flat;
Monday closed NEGATIVE with 24 decliners, 19 advancers and 2 flat;
Friday closed POSITIVE with 19 decliners, 24 advancers and 2 flat;
Thursday closed POSITIVE with 14 decliners, 29 advancers and 2 flat;
Wednesday closed NEGATIVE with 25 decliners, 16 advancers and 4 flat;
Tuesday closed POSITIVE with 14 decliners, 29 advancers and 2 flat;
Monday closed POSITIVE with 19 decliners, 24 advancers and 2 flat;
Friday closed NEGATIVE with 37 decliners, 4 advancers and 4 flat;
Thursday closed POSITIVE with 16 decliners, 27 advancers and 2 flat;
Last Wednesday (8/1) closed NEGATIVE with 23 decliners, 21 advancers and 1 flat;
Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.
Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.
